224 related articles for article (PubMed ID: 15100163)
1. Involvement of endogenous CCK and CCK1 receptors in colonic motor function.
Varga G; Bálint A; Burghardt B; D'Amato M
Br J Pharmacol; 2004 Apr; 141(8):1275-84. PubMed ID: 15100163
[TBL] [Abstract][Full Text] [Related]
2. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
Scarpignato C; Pelosini I
Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats.
Wu CL; Doong ML; Wang PS
Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924
[TBL] [Abstract][Full Text] [Related]
4. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.
Cremonini F; Camilleri M; McKinzie S; Carlson P; Camilleri CE; Burton D; Thomforde G; Urrutia R; Zinsmeister AR
Am J Gastroenterol; 2005 Mar; 100(3):652-63. PubMed ID: 15743365
[TBL] [Abstract][Full Text] [Related]
5. Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome.
Serra J; Caballero N
Expert Opin Pharmacother; 2016 Oct; 17(14):1969-74. PubMed ID: 27590736
[TBL] [Abstract][Full Text] [Related]
6. Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls.
van der Schaar PJ; van Hoboken E; Ludidi S; Masclee AA
Colorectal Dis; 2013 Jan; 15(1):e29-34. PubMed ID: 23006632
[TBL] [Abstract][Full Text] [Related]
7. CCK1 antagonists: are they ready for clinical use?
Peter SA; D'Amato M; Beglinger C
Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
Niederau C; Faber S; Karaus M
Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
[TBL] [Abstract][Full Text] [Related]
9. Effect of CCK and its antagonists on gastric emptying.
Scarpignato C; Varga G; Corradi C
J Physiol Paris; 1993; 87(5):291-300. PubMed ID: 8298606
[TBL] [Abstract][Full Text] [Related]
10. [Applicability of CCK receptor antagonists in physiologic and therapeutic studies].
Heintges T; Niederau C
Z Gastroenterol; 1992 May; 30(5):337-43. PubMed ID: 1632116
[TBL] [Abstract][Full Text] [Related]
11. Peripheral apelin-13 administration inhibits gastrointestinal motor functions in rats: The role of cholecystokinin through CCK
Bülbül M; Sinen O; Birsen İ; Izgüt-Uysal V
Neuropeptides; 2017 Jun; 63():91-97. PubMed ID: 28012561
[TBL] [Abstract][Full Text] [Related]
12. Effect of rectal distension on gallbladder emptying and circulating gut hormones.
van Hoek F; Mollen RM; Hopman WP; Kuijpers HH; Jansen JB
Eur J Clin Invest; 2000 Nov; 30(11):988-94. PubMed ID: 11114961
[TBL] [Abstract][Full Text] [Related]
13. [Role of gut hormones in irritable bowel syndrome].
Morise K; Furusawa A; Yamamoto H; Saito H
Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
[TBL] [Abstract][Full Text] [Related]
14. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
15. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.
Wang HH; Portincasa P; Wang DQ
Curr Med Chem; 2019; 26(19):3407-3423. PubMed ID: 28625150
[TBL] [Abstract][Full Text] [Related]
16. CCK antagonists: pharmacology and therapeutic interest.
Wettstein JG; Buéno L; Junien JL
Pharmacol Ther; 1994; 62(3):267-82. PubMed ID: 7972336
[TBL] [Abstract][Full Text] [Related]
17. Postprandial effect of gastrointestinal hormones and gastric activity in patients with irritable bowel syndrome.
Furgała A; Ciesielczyk K; Przybylska-Feluś M; Jabłoński K; Gil K; Zwolińska-Wcisło M
Sci Rep; 2023 Jun; 13(1):9420. PubMed ID: 37296188
[TBL] [Abstract][Full Text] [Related]
18. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity.
Mönnikes H; Tebbe JJ; Hildebrandt M; Arck P; Osmanoglou E; Rose M; Klapp B; Wiedenmann B; Heymann-Mönnikes I
Dig Dis; 2001; 19(3):201-11. PubMed ID: 11752838
[TBL] [Abstract][Full Text] [Related]
19. Interaction between CCK and opioids in the modulation of the rectocolonic inhibitory reflex in rats.
Gué M; del Rio C; Junien JL; Buéno L
Am J Physiol; 1995 Aug; 269(2 Pt 1):G240-5. PubMed ID: 7653564
[TBL] [Abstract][Full Text] [Related]
20. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay.
Liddle RA
Gastroenterol Clin North Am; 1989 Dec; 18(4):735-56. PubMed ID: 2482253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
